Abstract
Lithium has been an FDA-approved and preferred drug for the treatment of mood disorders for many years, and cumulative evidence has pointed towards its potential use as an anti-cancer agent. Previous studies in our laboratory have demonstrated that lithium induces apoptotic cell death in HL-60 promyelocytes at concentrations of 10 mM and above. A lithium-tolerant HL-60 sub-clone, resistant to up to 15 mM lithium, was also generated and its growth profile reported. Treatment of cells with lithium resulted in a dose-dependent induction of p53, retinoblastoma (Rb) and bax expression which was accompanied by concomitant inhibition of bcl-2 expression as demonstrated using immunohistochemical microscopy. These results seem to suggest that lithium induced cell death in these cells by inhibiting expression of anti-apoptotic protein, bcl-2, while inducing higher expression of its pro-apoptotic counterparts which include bax. Expression of bax and bcl-2 is also linked to expression of inflammation-regulating cytokines. Using ELISA assays, lithium was demonstrated to induce production of pro-inflammatory cytokines, IL-6 and TNF-α, while inhibiting release of anti-inflammation-related IL-2 and IL-10 in a dose-dependent fashion. Our findings identify a critical function for lithium in modulating pro- versus anti-apoptotic gene expression and pro- versus anti-inflammatory cytokines in vitro and provide a rationale for suggesting a promising role of lithium in regulation of inflammation and cancer growth.
References
Cade JFJ (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 36:349–352
Wang ZF, Fessler EB, Chuang DM (2011) Beneficial effects of mood stabilizers lithium, valproate, and lamotrigine in experimental stroke models. doi: 10.1038/aps.2011.140. Accessed 7 Nov 2011
Nahman S, Belmaker RH, Azab AN (2011) Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells. Innate Immun. http://www.ncbi.nlm.nih.gov/pubmed/21994254. Accessed 12 October 2011
Matsebatlela TM, Mogodiri RK, Hart DA, Gallicchio VS, Becker RW (2000) Resistance to lithium-induced apoptosis in a lithium tolerant clone of HL-60 promyelocytes. J Trace Microprobe Techn 18:163–170
Becker RW, Tyobeka EM (1990) Lithium enhances proliferation of the HL-60 promyelocytic leukemia cells. Leukemia Res 14:879–884
Madiehe AM, Mampuru LJ, Tyobeka EM (1995) Induction of apoptosis in HL-60 by lithium. Biochem Biophys Res Commun 209:768–774
Becker RW, Tyobeka (1996) Lithium: effects on proliferation, differentiation and toxicity in cell cultures. In: Gallicchio VS, Birch NJ (eds) Lithium: Biochemical and clinical advances. Weidner Publishing, Cheshire, pp 19–37
Mampuru LJ, Abotsi EK, Wachira SJM (1999) Calyculin-A potentiates growth and apoptotic effects of lithium in HL-60 cells. J Trace Microprobe Tech 17:367–378
Shai LJ, Abotsi EK, Tyobeka EM, Wachira JM (2003) Partial involvement of c-jun protooncogene in growth enhancing and cytotoxic effects of lithium in vitro. Cell MolBiol 49:1137–43
Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. ProcNatlAcadSci USA 93:8455–9
Stambolic V, Ruel L, Woodgett JR (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. CurrBiol 6:1664–8
Jope RS (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends PharmacolSci 24:441–3
Chiu CT, Chuang DM (2010) Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. PharmacolTher 128:281–304
Ryves WJ, Harwood AJ (2001) Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280:720–5
Chuang DM, Wang Z, Chiu CT (2011) GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke. Front MolNeurosci 4:15
Ozaki N, Chuang DM (1997) Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem 69:2336–44
Chen RW, Qin ZH, Ren M, Kanai H, Chalecka-Franaszek E, Leeds P et al (2003) Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection. J Neurochem 84:566–75
Wang MJ, Huang HY, Chen WF, Chang HF, Kuo JS (2010) Glycogen synthase kinase-3beta inactivation inhibits tumor necrosis factor alpha production in microglia by modulating nuclear factor kappaB and MLK3/JNK signaling cascades. J Neuroinflammation 7:99
Huang WC, Lin YS, Wang CY, Tsai CC, Tseng HC, Chen CL et al (2009) Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 128:275–86
Jeso BD, Ulianich L, Racioppi I, D’Armiento F, Felicielo A, Pacifico F, Consiglio E, Formisano S (1995) Serum withdrawal induces apoptotic cell death in KI-RAS transformed but not in normal differentiated thyroid cells. Biochem Biophys Res Commun 214:819–824
Becker RW, Gallicchio VS (1996) Mitogenic effects of lithium on the hematopoietic system. J Trace Microprobe Techn 14:799–812
Becker RW, Gallicchio VS (1997) Modulation by lithium of the formed elements of blood. In: Ermidou-Pollet S (ed) Proceedings of the international symposium on trace elements in humans. G. Morogianni, Acharnai, pp 525–547
Lucas KC, Hart DA, Becker RW (2010) Porcine proximal tubular cells (LLC-PK1) are able to tolerate high levels of lithium chloride in vitro: assessment of the influence of 1–20 mM LiCl on cell death and alterations in cell biology and biochemistry. Cell BiolInt 34:225–33
Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA (1999) P53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97:527–538
Scholtz W (1996) IL-6 in disease: cause or cure? Immunopathology 3:131–150
Parry SL, Sebbag M, Feldman M, Brennan FM (1997) Contact with T cells modulates monocytes IL-10 production. J Immunol 158:3673–3681
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsebatlela, T., Gallicchio, V. & Becker, R. Lithium Modulates Cancer Cell Growth, Apoptosis, Gene Expression and Cytokine Production in HL-60 Promyelocytic Leukaemia Cells and Their Drug-Resistant Sub-clones. Biol Trace Elem Res 149, 323–330 (2012). https://doi.org/10.1007/s12011-012-9438-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-012-9438-1